Media headlines about Express Scripts (NASDAQ:ESRX) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Express Scripts earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 48.0837145252765 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:
- Express Scripts (ESRX) Board Declares Share Repurchase Plan (americanbankingnews.com)
- Express Scripts Getting Closer To Key Technical Benchmark (finance.yahoo.com)
- Express Scripts Holding Company (ESRX) – Summary of what has been Unusual Volume trade – Wall Street Morning (wallstreetmorning.com)
- Stocks Trend Prediction: GGP Inc. (GGP), Express Scripts Holding Company (ESRX) – Market Movers (financialqz.com)
- Express Scripts Holding Company (ESRX) VP Christine Houston Sells 10,104 Shares (americanbankingnews.com)
A number of brokerages recently weighed in on ESRX. Jefferies Group set a $80.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a report on Friday, December 15th. SunTrust Banks set a $82.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a report on Thursday, December 14th. BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday, December 14th. Raymond James Financial reiterated a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Finally, Robert W. Baird upgraded shares of Express Scripts from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $72.00 to $81.00 in a report on Friday, December 15th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Express Scripts currently has an average rating of “Hold” and a consensus price target of $74.40.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. During the same quarter in the previous year, the business posted $1.74 EPS. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. sell-side analysts expect that Express Scripts will post 7.03 EPS for the current fiscal year.
Express Scripts announced that its board has approved a stock repurchase plan on Monday, December 18th that allows the company to repurchase 45,000,000 shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
In other news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total value of $40,103.91. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The stock was purchased at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the transaction, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Insiders own 0.68% of the company’s stock.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.